Bestatin Activators encompass a range of chemical compounds that serve to indirectly amplify the protease inhibitory activity of Bestatin through various biochemical pathways. Compounds such as (S)-2-Amino-6-[(aminooxy)acetyl]amino]hexanoic acid and Amastatin work as competitive inhibitors for other aminopeptidases, which may relieve competitive inhibition on Bestatin's target proteases, effectively enhancing its inhibition potential.
Similarly, Aminooxyacetic acid and Boroleucine inhibit aminotransferases, leading to an accumulation of amino acids that may provide a more abundant substrate profile for Bestatin's proteolytic targets. Gabaculine, with its selective inhibition of GABA aminotransferase, may indirectly modulate protease activity within the nervous system, potentially aiding Bestatin's functional role. Moreover, Carboxyamidotriazole's influence on calcium channels could create an intracellular milieu that favors Bestatin's action on proteases, while Kynurenine could leverage immunomodulatory effects to affect proteoly
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Boroleucine acts as an inhibitor of certain aminotransferases. This inhibition can lead to an accumulation of substrates for proteases, potentially allowing Bestatin to more effectively inhibit its target proteases. | ||||||
Gabaculine | 59556-17-1 | sc-200473 sc-200473A sc-200473B | 10 mg 50 mg 250 mg | $354.00 $884.00 $3069.00 | 5 | |
Gabaculine is a selective inhibitor of GABA aminotransferase. Its inhibition can lead to altered neurotransmitter levels, which could indirectly enhance the activity of Bestatin by affecting protease activity in the nervous system. | ||||||
Hydroxylamine solution | 7803-49-8 | sc-250136 | 100 ml | $72.00 | ||
Hydroxylamine can inactivate certain enzymes through the oxidation of their active sites. This inactivation could lead to a reduced degradation of extracellular matrix components, enhancing the activity of Bestatin by preserving its target substrates. | ||||||
Phenylarsine oxide | 637-03-6 | sc-3521 | 250 mg | $41.00 | 4 | |
This compound is an inhibitor of thiol-reactive enzymes. By modifying the activity of these enzymes, it could indirectly enhance the activity of Bestatin by affecting the protease-protease inhibitor balance. | ||||||